Invenomic Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-288,964
Closed -$5.27M 150
2022
Q1
$5.27M Buy
288,964
+137,666
+91% +$3.36M 0.56% 55
2021
Q4
$4.18M Buy
151,298
+19,902
+15% +$533K 0.89% 41
2021
Q3
$3.66M Sell
131,396
-10,167
-7% -$288K 1.19% 30
2021
Q2
$4.15M Sell
141,563
-25,073
-15% -$760K 0.99% 20
2021
Q1
$5.29M Buy
166,636
+31,941
+24% +$937K 1.18% 12
2020
Q4
$2.8M Sell
134,695
-45,169
-25% -$843K 0.71% 24
2020
Q3
$2.79M Buy
179,864
+52,633
+41% +$907K 1.54% 12
2020
Q2
$2.33M Buy
127,231
+32,190
+34% +$567K 1.72% 10
2020
Q1
$1.47M Sell
95,041
-172,699
-65% -$4.16M 1.2% 27
2019
Q4
$8.01M Buy
+267,740
New +$6.96M 3.22% 1

Other funds holding BHC